China Shineway Pharmaceutical Group Limited (CSWYY)

OTCMKTS · Delayed Price · Currency is USD
19.25
+0.72 (3.89%)
At close: May 13, 2025
Market Cap944.07M +15.8%
Revenue (ttm)466.80M -20.5%
Net Income115.61M -25.0%
EPS0.15 -25.3%
Shares Outn/a
PE Ratio8.17
Forward PE7.86
Dividend1.16 (6.02%)
Ex-Dividend DateSep 10, 2025
Volume100
Average Volume361
Open19.25
Previous Close18.53
Day's Range19.25 - 19.25
52-Week Range18.53 - 19.25
Beta0.88
RSIn/a
Earnings DateMar 30, 2026

About CSWYY

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, ortho... [Read more]

Sector Healthcare
Founded 2002
Employees 2,867
Stock Exchange OTCMKTS
Ticker Symbol CSWYY
Full Company Profile

Financial Performance

In 2024, CSWYY's revenue was 3.78 billion, a decrease of -16.35% compared to the previous year's 4.52 billion. Earnings were 840.05 million, a decrease of -13.35%.

Financial numbers in CNY Financial Statements